Patient | Tumor type (AJCC stage) | C-pGTV (mL) | SUVmax | BTV (mL) 10% TL | BTV (mL) 20% TL | BTV (mL) 30% TL | BTV (mL) 40% TL | BTV (mL) 50% TL | sTL | sSUV |
---|---|---|---|---|---|---|---|---|---|---|
1 | HPC (T2N2) | 43.3 | 30.6 | 47.9 | 35.5 | 30 | 25.4 | 19.2 | 13% | 3.98 |
2 | OPC (T4N1) | 75.4 | 17.2 | 92.1 | 42.8 | 31.6 | 24.8 | 18.2 | 16% | 2.75 |
3 | NPC (T4N2) | 110.2 | 17 | 139.2 | 77.3 | 59.3 | 47 | 37.5 | 15% | 2.55 |
4 | NPC (T3N1) | 30.4 | 14.6 | 40.7 | 22.7 | 14.6 | 8.3 | 2.8 | 15% | 2.19 |
5 | NPC (T1N1) | 14.8 | 15.7 | 36.6 | 12 | 7.2 | 5.4 | 4.2 | 17% | 2.21 |
6 | OPC (T3N1) | 47.7 | 24.1 | 75.8 | 33.3 | 21.1 | 14.1 | 9.9 | 14% | 3.37 |
7 | NPC (T4N2) | 38.7 | 8.0 | - | 60 | 30.8 | 17.4 | 12.3 | 27% | 2.16 |
8 | NPC (T3N2) | 44.6 | 17.0 | 64.7 | 33.6 | 24.5 | 17.5 | 13.6 | 15% | 2.55 |
9 | NPC (T2N1) | 12.8 | 7.8 | 39.6 | 13 | 5.6 | 4 | 2.4 | 21% | 1.64 |
10 | NPC (T4N1) | 35.5 | 8.2 | 80.7 | 44 | 21.9 | 10 | 5.6 | 23% | 1.89 |
11 | NPC (T1N1) | 9.6 | 9.0 | 37.6 | 13.8 | 4.9 | 2.2 | 1.2 | 23% | 2.07 |
12 | NPC (T3N3) | 27.8 | 17.5 | 49.9 | 13.7 | 9.2 | 5.3 | 3.2 | 14% | 2.45 |
13 | NPC (T3N2) | 37.1 | 12.9 | 67.4 | 37.9 | 20.6 | 12 | 9.5 | 20% | 2.57 |
14 | NPC (T2N2) | 22.4 | 8.1 | - | 35.6 | 14.8 | 9.2 | 5.9 | 27% | 2.19 |
15 | HPC (T2N1) | 14.3 | 12.2 | 46.8 | 14.5 | 5.2 | 3.1 | 2.3 | 20% | 2.44 |